Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4zdc | CO8 | 3,2-trans-enoyl-CoA isomerase | 5.3.3.8 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4zdc | CO8 | 3,2-trans-enoyl-CoA isomerase | 5.3.3.8 | 1.000 | |
4zdb | CAA | 3,2-trans-enoyl-CoA isomerase | 5.3.3.8 | 0.611 | |
3q0g | BCO | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.501 | |
3q0g | COA | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.486 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.480 | |
3zv7 | NHG | Acetylcholinesterase | 3.1.1.7 | 0.476 | |
1pdh | FAS | p-hydroxybenzoate hydroxylase | / | 0.474 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.473 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.473 | |
2d1o | FA4 | Stromelysin-1 | 3.4.24.17 | 0.472 | |
4wx2 | F6F | Tryptophan synthase alpha chain | / | 0.472 | |
4wx2 | F6F | Tryptophan synthase beta chain | 4.2.1.20 | 0.472 | |
1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
2e0n | SAH | Precorrin-2 C20-methyltransferase | / | 0.469 | |
2wd9 | IBP | Acyl-coenzyme A synthetase ACSM2A, mitochondrial | 6.2.1.2 | 0.469 | |
1gpn | HUB | Acetylcholinesterase | 3.1.1.7 | 0.468 | |
3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.468 | |
3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.467 | |
3mje | NDP | AmphB | / | 0.467 | |
2w6q | OA5 | Biotin carboxylase | 6.3.4.14 | 0.466 | |
1bwl | FMN | NADPH dehydrogenase 1 | 1.6.99.1 | 0.464 | |
1gaq | FAD | Ferredoxin | / | 0.464 | |
1i59 | ADP | Chemotaxis protein CheA | 2.7.13.3 | 0.464 | |
1dub | CAA | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.463 | |
4bfx | ZVX | Pantothenate kinase | 2.7.1.33 | 0.463 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.462 | |
4g2j | 0WF | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.461 | |
3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.461 | |
3ddw | 055 | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.460 | |
4eji | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.460 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.458 | |
3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.458 | |
3glu | LYS_VAL_MET | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.458 | |
3ivc | FG4 | Pantothenate synthetase | 6.3.2.1 | 0.458 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.457 | |
1p7t | ACO | Malate synthase G | / | 0.456 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.456 | |
3b7d | CNI | Glutamate receptor 2 | / | 0.455 | |
3w5u | FAD | Ferredoxin | / | 0.455 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.454 | |
2hk9 | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.454 | |
1x8l | OXR | Retinol dehydratase | / | 0.453 | |
3opx | U5P | Suppressor of disruption of TFIIS | / | 0.453 | |
6std | MS2 | Scytalone dehydratase | 4.2.1.94 | 0.453 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
2ha6 | SCK | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.452 | |
4ozt | P1A | Ecdysone receptor, putative | / | 0.452 | |
1beu | IPL | Tryptophan synthase alpha chain | / | 0.451 | |
3t3r | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.451 | |
3w5h | FAD | NADH-cytochrome b5 reductase 3 | 1.6.2.2 | 0.451 | |
1mj3 | HXC | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.450 | |
2a9z | 26A | Adenosine kinase | 2.7.1.20 | 0.450 | |
2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.450 | |
3br3 | ET | HTH-type transcriptional regulator QacR | / | 0.450 | |
3cmf | PDN | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.450 | |
1d3p | BT3 | Prothrombin | 3.4.21.5 | 0.449 | |
1tkb | N1T | Transketolase 1 | 2.2.1.1 | 0.449 | |
3h3q | H13 | Collagen type IV alpha-3-binding protein | / | 0.449 | |
1fmj | RTL | Retinol dehydratase | / | 0.448 | |
1qoq | IGP | Tryptophan synthase alpha chain | / | 0.448 | |
2whq | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
3bnk | FMN | Flavoredoxin | / | 0.448 | |
1eve | E20 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
1nm6 | L86 | Prothrombin | 3.4.21.5 | 0.447 | |
1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
3tlj | SAH | Uncharacterized protein | / | 0.447 | |
4b67 | FAD | L-ornithine N(5)-monooxygenase | / | 0.447 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
4geb | 0LD | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.447 | |
4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.447 | |
1ozq | PRF | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.445 | |
2qim | ZEA | Class 10 plant pathogenesis-related protein | / | 0.445 | |
3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.445 | |
3mhp | FAD | Ferredoxin--NADP reductase, leaf isozyme, chloroplastic | 1.18.1.2 | 0.445 | |
3n3z | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
4bfw | ZVW | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4l1x | NAP | Aldo-keto reductase family 1 member C2 | / | 0.445 | |
3ipq | 965 | Oxysterols receptor LXR-alpha | / | 0.444 | |
4epl | JAI | Jasmonic acid-amido synthetase JAR1 | 6.3.2 | 0.444 | |
4rrm | A3T | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.444 | |
4tmc | FMN | Old yellow enzyme | / | 0.444 | |
5cp8 | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
1fml | RTL | Retinol dehydratase | / | 0.443 | |
1m9j | CLW | Nitric oxide synthase, endothelial | 1.14.13.39 | 0.443 | |
1w6r | GNT | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.443 | |
2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
3jyp | NAD | Quinate/shikimate dehydrogenase (NAD(+)) | / | 0.443 | |
3w3z | GTP | GTP-binding nuclear protein Ran | / | 0.443 | |
4b67 | NAP | L-ornithine N(5)-monooxygenase | / | 0.443 | |
4ead | 0NP | Thymidine phosphorylase | 2.4.2.4 | 0.443 | |
2gyw | OBI | Acetylcholinesterase | 3.1.1.7 | 0.442 | |
3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.442 | |
4iwv | 1J9 | Glucokinase | 2.7.1.2 | 0.442 | |
4ocp | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.442 | |
1aqu | EST | Estrogen sulfotransferase, testis isoform | 2.8.2.4 | 0.441 | |
1gaw | FAD | Ferredoxin | / | 0.441 | |
1o76 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
1pq6 | 965 | Oxysterols receptor LXR-beta | / | 0.441 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.441 | |
3hzi | ATP | Serine/threonine-protein kinase toxin HipA | / | 0.441 | |
3lzw | NAP | Ferredoxin--NADP reductase 2 | 1.18.1.2 | 0.441 | |
3mau | PLR | Putative sphingosine-1-phosphate lyase | / | 0.441 | |
4g2l | 0WL | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
1g05 | BBH | Stromelysin-1 | 3.4.24.17 | 0.440 | |
1q84 | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
2ea2 | F77 | Methionine aminopeptidase 2 | / | 0.440 | |
2ewm | NAD | (S)-1-Phenylethanol dehydrogenase | 1.1.1.311 | 0.440 | |
2gev | COK | Pantothenate kinase | 2.7.1.33 | 0.440 | |
3f90 | FMN | Flavodoxin | / | 0.440 | |
3h1v | TK1 | Glucokinase | 2.7.1.2 | 0.440 | |
3sp9 | IL2 | Peroxisome proliferator-activated receptor delta | / | 0.440 | |
4b1r | ITC | Tetracycline repressor protein class D | / | 0.440 | |
4eh8 | IRG | Mitogen-activated protein kinase 14 | / | 0.440 | |
4pyo | SAH | Catechol O-methyltransferase | 2.1.1.6 | 0.440 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.440 | |
4zqc | F6F | Tryptophan synthase alpha chain | / | 0.440 |